Consistent with these observations, we further found in a later analysis of 216 patients with all breast cancer subtypes that high NDRG1 expression was associated with aggressive breast tumor features (i.e., ER− status, triple-negative disease, and high grade) and was also independently associated with poor outcome [51]. Here, NDRG1 is linked to breast carcinoma.